본문 바로가기

US · 21 CFR

21 CFR 600.15

Temperatures during shipment.

21 CFR Part 600 › Subpart B—Establishment Standards

조항 원문

The following products shall be maintained during shipment at the specified temperatures:

(a) Products.

Product Temperature

Cryoprecipitated AHF −18 °C or colder.

Measles and Rubella Virus Vaccine Live 10 °C or colder.

Measles Live and Smallpox Vaccine Do.

Measles, Mumps, and Rubella Virus Vaccine Live Do.

Measles and Mumps Virus Vaccine Live Do.

Measles Virus Vaccine Live Do.

Mumps Virus Vaccine Live Do.

Fresh Frozen Plasma −18 °C or colder.

Liquid Plasma 1 to 10 °C.

Plasma −18 °C or colder.

Platelet Rich Plasma Between 1 and 10 °C if the label indicates storage between 1 and 6 °C, or all reasonable methods to maintain the temperature as close as possible to a range between 20 and 24 °C, if the label indicates storage between 20 and 24 °C.

Platelets Between 1 and 10 °C if the label indicates storage between 1 and 6 °C, or all reasonable methods to maintain the temperature as close as possible to a range between 20 to 24 °C, if the label indicates storage between 20 and 24 °C.

Poliovirus Vaccine Live Oral Trivalent 0 °C or colder.

Poliovirus Vaccine Live Oral Type I Do.

Poliovirus Vaccine Live Oral Type II Do.

Poliovirus Vaccine Live Oral Type III Do.

Red Blood Cells (liquid product) Between 1 and 10 °C.

Red Blood Cells Frozen −65 °C or colder.

Rubella and Mumps Virus Vaccine Live 10 °C or colder.

Rubella Virus Vaccine Live Do.

Smallpox Vaccine (Liquid Product) 0 °C or colder.

Source Plasma −5 °C or colder.

Source Plasma Liquid 10 °C or colder.

Whole Blood Blood that is transported from the collecting facility to the processing facility shall be transported in an environment capable of continuously cooling the blood toward a temperature range of 1 to 10 °C, or at a temperature as close as possible to 20 to 24 °C for a period not to exceed 6 hours. Blood transported from the storage facility shall be placed in an appropriate environment to maintain a temperature range between 1 to 10 °C during shipment.

Yellow Fever Vaccine 0 °C or colder.

(b) Exemptions. Exemptions or modifications shall be made only upon written approval, in the form of a supplement to the biologics license application, approved by the Director, Center for Biologics Evaluation and Research.

본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.

각주·출처 표기

  • [39 FR 39872, Nov. 12, 1974, as amended at 49 FR 23833, June 8, 1984; 50 FR 4133, Jan. 29, 1985; 50 FR 9000, Mar. 6, 1985; 55 FR 11013, Mar. 26, 1990; 59 FR 49351, Sept. 28, 1994; 64 FR 56449, Oct. 20, 1999]

출처: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · 수집일 2026-11-16

Weekly Newsletter

FDA·EU·식약처 실사 지적, 매주 받아 보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

확인 메일의 버튼을 누르면 구독이 완료됩니다 · 언제든 해지할 수 있습니다